IN THE NEWS

Mayne Pharma Announces Strategic investment in US Facilities

ABOUT US

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma provides contract development and manufacturing services to more than 100 clients worldwide...

PRODUCTS

Mayne Pharma has enhanced its generic products portfolio with 42 products acquired from Teva/Allergan. We now offer branded and generic drugs for a range of therapeutic areas, including oral contraception, oncology, dermatology and cardiology, in an array of dosage forms...

PARTNERING

One of the keys to Mayne Pharma’s success has been the implementation of strategic partnerships and alliances by licensing products that we are able to market in the USA or Australia and to develop partnerships for the global marketing of products developed by Mayne Pharma...

SPECIALTY TECHNOLOGIES

Mayne Pharma has a 30-year track record of innovation and success developing new oral drug delivery systems and these technologies have been successfully commercialized in numerous products that have been marketed around the world...

FOR INVESTORS

Last Updated:

ASX:

1.05 AUD

Change: / Open:
Low: High:
Close: Volume:
Market Cap: 52 Week: -